PAC1 Receptors: Shapeshifters in Motion

被引:0
作者
Chenyi Liao
Victor May
Jianing Li
机构
[1] University of Vermont,Department of Chemistry
[2] University of Vermont Larner College of Medicine,Department of Neurological Sciences
来源
Journal of Molecular Neuroscience | 2019年 / 68卷
关键词
PACAP; PAC1 receptor; Molecular dynamics; Markov state modeling; Transition path theory;
D O I
暂无
中图分类号
学科分类号
摘要
Shapeshifters, in common mythology, are entities that can undergo multiple physical transformations. As our understanding of G protein-coupled receptors (GPCRs) has accelerated and been refined over the last two decades, we now understand that GPCRs are not static proteins, but rather dynamic structures capable of moving from one posture to the next, and adopting unique functional characteristics at each transition. This model of GPCR dynamics underlies our current understanding of biased agonism—how different ligands to the same receptor can generate different intracellular signals—and constitutive receptor activity, or the level of unbound basal receptor signaling that can be attenuated by inverse agonists. From information derived from related class B receptors, we have recently modeled the structure and molecular dynamics of the full-length pituitary adenylate cyclase activating polypeptide (PACAP, Adcyap1)—selective PAC1 receptor (PAC1R, Adcyap1r1). The class B receptors are different from the class A GPCRs in part from the presence of a large extracellular domain (ECD); the transitions of the ECD along with the dynamics of the transmembrane domains (TMD or 7TM) of the PAC1R describes a series of open- and closed-state conformations that appear to identify the mechanisms for receptor activation. The PAC1R shapeshifts also have the ability of delineating the mechanisms and the design of reagents that may direct biased agonism (or antagonism) for potential therapeutics.
引用
收藏
页码:331 / 339
页数:8
相关论文
共 328 条
  • [1] Adan RA(2003)Inverse agonism gains weight Trends Pharmacol Sci 24 315-321
  • [2] Kas MJ(2010)Experimental and computational determination of tRNA dynamics FEBS Lett 584 376-386
  • [3] Alexander RW(1991)Tissue distribution of PACAP as determined by RIA: highly abundant in the rat brain and testes Endocrinology 129 2787-2789
  • [4] Eargle J(2010)Exit strategies for charged tRNA from GluRS J Mol Biol 397 1350-1371
  • [5] Luthey-Schulten Z(2013)Alternative splicing of the pituitary adenylate cyclase-activating polypeptide receptor PAC1: mechanisms of fine tuning of brain activity Front Endocrinol 4 55-201
  • [6] Arimura A(2009)Using generalized ensemble simulations and Markov state models to identify conformational states Methods 49 197-27710
  • [7] Somogyvári-Vigh A(1999)Pituitary adenylate cyclase-activating polypeptides directly stimulate sympathetic neuron neuropeptide Y release through PAC(1) receptor isoform activation of specific intracellular signaling pathways J Biol Chem 274 27702-960
  • [8] Miyata A(2015)Transmembrane signal transduction by peptide hormones via family B G protein-coupled receptors Front Pharmacol 6 264-649
  • [9] Mizuno K(2017)Extending the structural view of class B GPCRs Trends Biochem Sci 42 946-177
  • [10] Coy DH(2018)PACAP and its role in primary headaches J Headache Pain 19 21-843